View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Johnson & Johnson: Update to credit analysis

Our credit view of this issuer reflects its strong growth prospects, solid profit margins and cash flow, tempered by ongoing litigation risks.

Moody's Ratings announces completion of a periodic review of ratings o...

Announcement of Periodic Review: Moody's Ratings announces completion of a periodic review of ratings of Johnson& Johnson. Global Credit Research- 26 Mar 2026. New York, March 26, 2026-- Moody's Ratings has completed a periodic review of the ratings of Johnson& Johnson and other ratings that are associated with this issuer.

Abbott Laboratories - December 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Baxter International Inc. - December 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Johnson & Johnson - December 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Baxter International Inc.: Update following revision in outlook to neg...

Our credit view of this issuer reflects its strong market positions across a broad range of product lines, constrained by its modest revenue growth.

Moody's Ratings affirms Baxter's Baa3/P-3 ratings; revises outlook to ...

Moody's Ratings (Moody's) affirmed the ratings of Baxter International Inc. (Baxter) including the Baa3 senior unsecured ratings, (P)Baa3 senior unsecured shelf rating, and the Prime-3 commercial paper rating. At the same time, we revised the outlook to negative from stable. The revision in the ou...

Moody's Ratings assigns Aa3 rating to Abbott's sr. unsecured notes; ou...

Moody's Ratings (Moody's) assigned a Aa3 rating to the new senior unsecured notes issuance of Abbott Laboratories (Abbott). In addition, we assigned a (P)Aa3 senior unsecured shelf registration. Abbott's existing ratings remain unchanged, and the outlook remains unchanged at stable. Abbott will us...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 14, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 7, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: February 6, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Abbott Laboratories: 1 director

A director at Abbott Laboratories bought 10,000 shares at 108.733USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

Boston Scientific Corp: 1 director

A director at Boston Scientific Corp sold after exercising options/sold 160,901 shares at 93.495USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: January 31, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Boston Scientific Corporation: Update to credit analysis following Pen...

Our credit view of this issuer reflects its leading market positions and strong operating performance tempered by an ongoing appetite for acquisitions

Boston Scientific Corporation: Update to credit analysis following Pen...

Our credit view of this issuer reflects its leading market positions and strong operating performance tempered by an ongoing appetite for acquisitions

Johnson & Johnson: 1 director

A director at Johnson & Johnson sold 100,000 shares at 221.229USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: January 26, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Boston Scientific Corporation: Update to credit analysis following Pen...

Our credit view of this issuer reflects its leading market positions and strong operating performance tempered by an ongoing appetite for acquisitions

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch